Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda
Aline Uwimana, Eric Legrand, Barbara H. Stokes, et al.
Nature Medicine (2020) Vol. 26, Iss. 10, pp. 1602-1608
Open Access | Times Cited: 643

Showing 26-50 of 643 citing articles:

Current and emerging strategies to combat antimalarial resistance
Charlotte Rasmussen, Pedro L. Alonso, Pascal Ringwald
Expert Review of Anti-infective Therapy (2021) Vol. 20, Iss. 3, pp. 353-372
Open Access | Times Cited: 96
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
Mehul Dhorda, Chanaki Amaratunga, Arjen M. Dondorp
Current Opinion in Infectious Diseases (2021) Vol. 34, Iss. 5, pp. 432-439
Open Access | Times Cited: 91
Assessing risks of Plasmodium falciparum resistance to select next-generation antimalarials
Maëlle Duffey, Benjamin Blasco, Jeremy N. Burrows, et al.
Trends in Parasitology (2021) Vol. 37, Iss. 8, pp. 709-721
Open Access | Times Cited: 86
High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine
Judith Straimer, Preetam Gandhi, Katalin Csermak Renner, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 8, pp. 1411-1414
Open Access | Times Cited: 83
A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa
Leonard Ndwiga, Kelvin M. Kimenyi, Kevin Wamae, et al.
International Journal for Parasitology Drugs and Drug Resistance (2021) Vol. 16, pp. 155-161
Open Access | Times Cited: 79
Artemisinin-based combination therapy (ACT) and drug resistance molecular markers: A systematic review of clinical studies from two malaria endemic regions – India and sub-Saharan Africa
Aditi Arya, Loick Pradel Kojom Foko, Shewta Chaudhry, et al.
International Journal for Parasitology Drugs and Drug Resistance (2020) Vol. 15, pp. 43-56
Open Access | Times Cited: 77
Plasmodium falciparum resistance to ACTs: Emergence, mechanisms, and outlook
Faiza Amber Siddiqui, Xiaoying Liang, Liwang Cui
International Journal for Parasitology Drugs and Drug Resistance (2021) Vol. 16, pp. 102-118
Open Access | Times Cited: 72
Expansion Microscopy Reveals Plasmodium falciparum Blood-Stage Parasites Undergo Anaphase with A Chromatin Bridge in the Absence of Mini-Chromosome Maintenance Complex Binding Protein
Benjamin Liffner, Sabrina Absalon
Microorganisms (2021) Vol. 9, Iss. 11, pp. 2306-2306
Open Access | Times Cited: 69
Diagnosis, Treatment, and Prevention of Malaria in the US
Johanna P. Daily, Aurelia Minuti, Nazia Khan
JAMA (2022) Vol. 328, Iss. 5, pp. 460-460
Closed Access | Times Cited: 69
Malaria in 2022: Increasing challenges, cautious optimism
Prasanna Jagannathan, Abel Kakuru
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 65
Anopheles stephensi in Africa requires a more integrated response
Abraham Mnzava, April Monroe, Fredros O. Okumu
Malaria Journal (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 65
Plasmodium Kinases as Potential Drug Targets for Malaria: Challenges and Opportunities
Lauren B. Arendse, Susan Wyllie, Kelly Chibale, et al.
ACS Infectious Diseases (2021) Vol. 7, Iss. 3, pp. 518-534
Open Access | Times Cited: 62
Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018
Adama Gansané, Leah F. Moriarty, Didier Ménard, et al.
Malaria Journal (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 59
Artemisinin resistance in the malaria parasite, Plasmodium falciparum, originates from its initial transcriptional response
Lei Zhu, Rob W. van der Pluijm, Michal Kucharski, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 54
Artemisinin resistance and malaria elimination: Where are we now?
Borimas Hanboonkunupakarn, Joel Tärning, Sasithon Pukrittayakamee, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 42
Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells
Ghizal Siddiqui, Carlo Giannangelo, Amanda De Paoli, et al.
ACS Infectious Diseases (2022) Vol. 8, Iss. 1, pp. 210-226
Open Access | Times Cited: 39
Striving towards true equity in global health: A checklist for bilateral research partnerships
Daniel Z. Hodson, Yannick Mbarga Etoundi, Sunil Parikh, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 1, pp. e0001418-e0001418
Open Access | Times Cited: 35
Country wide surveillance reveals prevalent artemisinin partial resistance mutations with evidence for multiple origins and expansion of high level sulfadoxine-pyrimethamine resistance mutations in northwest Tanzania
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 27
Modeling policy interventions for slowing the spread of artemisinin-resistant pfkelch R561H mutations in Rwanda
Robert Zupko, Tran Dang Nguyen, Jean Claude Semuto Ngabonziza, et al.
Nature Medicine (2023) Vol. 29, Iss. 11, pp. 2775-2784
Open Access | Times Cited: 25
Highly potent, naturally acquired human monoclonal antibodies against Pfs48/45 block Plasmodium falciparum transmission to mosquitoes
Amanda Fabra-García, Sophia Hailemariam, Roos M. de Jong, et al.
Immunity (2023) Vol. 56, Iss. 2, pp. 406-419.e7
Open Access | Times Cited: 24
Impact of different mutations on Kelch13 protein levels, ART resistance, and fitness cost in Plasmodium falciparum parasites
Hannah Michaela Behrens, Sabine Schmidt, Isabelle G. Henshall, et al.
mBio (2024) Vol. 15, Iss. 6
Open Access | Times Cited: 11
High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing
Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 10
Evidence of artemisinin partial resistance in North-western Tanzania: clinical and drug resistance markers study
Deus S. Ishengoma, Celine I. Mandara, Catherine Bakari, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 9
Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine–pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey
Jonathan J. Juliano, David Giesbrecht, Alfred Simkin, et al.
The Lancet Microbe (2024) Vol. 5, Iss. 10, pp. 100920-100920
Open Access | Times Cited: 9
High frequency of artemisinin partial resistance mutations in the Great Lakes region revealed through rapid pooled deep sequencing
Neeva Wernsman Young, Pierre Gashema, David Giesbrecht, et al.
The Journal of Infectious Diseases (2024)
Closed Access | Times Cited: 9

Scroll to top